Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- IPACIndependent statistical analysis of Impact of Applying a Bandage Skin Hydrogel on the Pains of the Head and Neck in Patients With Cancer of Head and Neck Treated With Radiotherapy: primary endpoint…
- iPACK for Post-op Pain Following ACL Reconstruction: Complete Statistical AnalysisIndependent statistical analysis of iPACK for Post-op Pain Following ACL Reconstruction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05498870).
- IPATunity130Independent statistical analysis of A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer:…
- IPCIndependent statistical analysis of Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- IPCDIndependent statistical analysis of Impact of Pharmaceutical Care in Diabetics Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01580904).
- IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02803580).
- IPF-201Independent statistical analysis of Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ipilimumab Administered to Stage IIIC Stage IV Melanoma After Reg. T Cell Depletion With Denileukin Diftitox: Complete Statistical AnalysisIndependent statistical analysis of Ipilimumab Administered to Stage IIIC Stage IV Melanoma After Reg. T Cell Depletion With Denileukin Diftitox: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Ipilimumab and Local Radiation for Selected Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Ipilimumab and Local Radiation for Selected Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01769222).
- IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD: Complete Statistical AnalysisIndependent statistical analysis of IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- IPOD-AVIndependent statistical analysis of Assessing the Incidence of Postoperative Delirium Following Aortic Valve Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03950440).
- iPOP-UPIndependent statistical analysis of Dissemination and Implementation of Improving Pediatric Obesity Practice Using Prompts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05627011).
- IPSSARIndependent statistical analysis of A Public Health Intervention Program to Improve the Initial Management of Soft Tissue Sarcomas.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- IPV-102 Safety, Tolerability and Immunogenicity of TAK-195 in Healthy Infants, Toddlers and Adults: Complete Statistical AnalysisIndependent statistical analysis of IPV-102 Safety, Tolerability and Immunogenicity of TAK-195 in Healthy Infants, Toddlers and Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- IQSIndependent statistical analysis of Improving Quitline Support Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03538938).
- iQuit Mindfully: Text Messaging for Smoking Cessation: Complete Statistical AnalysisIndependent statistical analysis of iQuit Mindfully: Text Messaging for Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03029819).
- IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?: Complete Statistical AnalysisIndependent statistical analysis of IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- IRC002Independent statistical analysis of Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma: primary endpoint results, effect estimate…
- Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery: primary endpoint results,…
- Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction: Complete Statistical AnalysisIndependent statistical analysis of Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction: primary endpoint results, effect estimate with confidence interval,…
- Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers: Complete Statistical AnalysisIndependent statistical analysis of Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- IRISComplete statistical analysis of the IRIS trial of pioglitazone versus placebo after stroke or myocardial infarction, including trial design, time-to-event endpoints, Cox modeling, mixed-effects analysis, multiplicity, interim analysis, results, and statistical interpretation.
- IRISIndependent statistical analysis of Exercise and Inflammation in the Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00753363).
- IRISIndependent statistical analysis of Influenza Resistance Information Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00884117).
- IRM-seinIndependent statistical analysis of Benefit of a Diagnostic MRI in Case of Pathological Nipple Discharge With Normal Mammography / Ultrasound: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- IRMAIndependent statistical analysis of Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA): Complete Statistical AnalysisIndependent statistical analysis of Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients: Complete Statistical AnalysisIndependent statistical analysis of Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00721188).
- Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments: Complete Statistical AnalysisIndependent statistical analysis of Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments: primary endpoint results, effect estimate with confidence interval, sample-size…
- Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer: Complete Statistical AnalysisIndependent statistical analysis of Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00176501).
- Irrisept Versus Standard of Care in the Prevention of Surgical Site Infections: Complete Statistical AnalysisIndependent statistical analysis of Irrisept Versus Standard of Care in the Prevention of Surgical Site Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Irritation and Sensitization of Chlorhexidine Gluconate (CHG) Cloth: Complete Statistical AnalysisIndependent statistical analysis of Irritation and Sensitization of Chlorhexidine Gluconate (CHG) Cloth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02224625).
- Irritation Potential of Omeza Collagen Matrix Using Modified HRIPT: Complete Statistical AnalysisIndependent statistical analysis of Irritation Potential of Omeza Collagen Matrix Using Modified HRIPT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04510675).
- Is it Feasible?: Self-Affirmation for Hereditary Breast and Ovarian Cancer Genetic Counseling: Complete Statistical AnalysisIndependent statistical analysis of Is it Feasible?: Self-Affirmation for Hereditary Breast and Ovarian Cancer Genetic Counseling: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Is Non-Cardiac Chest Pain Caused by Sustained Longitudinal Smooth Muscle Contraction?: Complete Statistical AnalysisIndependent statistical analysis of Is Non-Cardiac Chest Pain Caused by Sustained Longitudinal Smooth Muscle Contraction?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Is Topical CBD Effective in Treating Thumb Joint Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Is Topical CBD Effective in Treating Thumb Joint Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04611347).
- ISABELA1Independent statistical analysis of A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care: primary endpoint results,…
- ISABELA2Independent statistical analysis of A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care: primary endpoint results,…
- ISALAIndependent statistical analysis of Analytical Treatment Interruption in HIV Positive Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02590354).
- Islamic Trauma Healing: Feasibility Study: Complete Statistical AnalysisIndependent statistical analysis of Islamic Trauma Healing: Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03761732).
- ISLANDIndependent statistical analysis of The ISLAND Study: InSuLa Assessed Needs for Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02137369).
- Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011): Complete Statistical AnalysisIndependent statistical analysis of Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Islet Transplantation for Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Islet Transplantation for Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00014911).
- iSmartHypIndependent statistical analysis of The Smart Hypertension Control Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03288142).